Mochi Health Lowered Compounded GLP-1 Prices
The telehealth provider updated its pricing model for weight loss medications to reflect lower introductory doses.
Updated on Sept. 29, 2026 in Weight Loss
Live Poll
Do you feel that access to weight-loss treatments is becoming more affordable for your household?
Mochi Health has introduced a new tiered pricing structure for its compounded GLP-1 medications, offering lower costs for patients beginning their treatment. The company also launched an integrated lab-testing service to streamline monitoring for members across the United States.
Why it matters
By tying monthly medication costs to dosage levels rather than a flat rate, this change aims to reduce financial barriers for patients starting on lower, introductory doses. The shift comes as demand for GLP-1 therapies continues to drive innovation in telehealth monitoring and care access.
Mochi Health reported new monthly starting costs of $60 for compounded semaglutide and $90 for compounded tirzepatide, representing a shift to dosage-dependent pricing. While these formulations have gained traction, they are not FDA-approved products and remain under ongoing scrutiny.
The players
Mochi Health
A telehealth platform that provides access to weight loss medications and remote clinical monitoring.
The details
Patients gain access to these medications through a 30-minute virtual consultation with a licensed healthcare provider to assess clinical needs. Members can now also order core health panel lab tests through the company portal, with bloodwork samples collected at participating laboratory locations. This testing service is currently unavailable for residents in New York, New Jersey, Rhode Island, and Hawaii.
Timeline
September 29, 2026: Mochi Health announced its new pricing model and lab-testing services.
Health Landscape
The introduction of dosage-based pricing for compounded GLP-1 medications signals a maturation of the direct-to-consumer telehealth weight loss market. It reflects an evolving approach to clinical care that prioritizes cost transparency alongside the necessary monitoring of metabolic health markers.
If you are considering compounded GLP-1 therapies, review the pricing tiers with your clinical provider to understand how costs may scale as your dosage changes. It is worth discussing with your doctor whether laboratory monitoring is appropriate for your specific health goals.
The takeaway
The move to dosage-based pricing offers a more tailored entry point for patients beginning GLP-1 weight loss therapy. Before choosing a provider, always verify whether they offer adequate clinical oversight and regular bloodwork monitoring to track your ongoing metabolic health.
Further reading
Explore the current state of Weight Loss treatments and clinical guidance.
Live Poll
Do you feel that access to weight-loss treatments is becoming more affordable for your household?
